Implantation of subcutaneous implantable cardioverter defibrillators in Europe: results of the European Heart Rhythm Association survey
Population
52 centres participating in the European Heart Rhythm Association (EHRA) electrophysiology research network
Design
Cross-sectional
Authors
Discussion
Loading...
Member takes
Implication
Survey reveals heterogeneous S-ICD practices across Europe; leaves open need for standardized indications and training protocols.
Structured PICO
P
Population
52 centres participating in the European Heart Rhythm Association (EHRA) electrophysiology research network
I
Intervention
Subcutaneous implantable cardioverter defibrillators (S-ICDs) implantation and management policies
O
Outcome
Overview of the current use, indications, techniques of implantation, and patient management policies for S-ICDs
This survey highlights that while S-ICD use is limited by cost and reimbursement issues in Europe, its adoption is expected to increase, primarily for patients with difficult vascular access or prior transvenous ICD complications.
Cite This Study
Bovéda et al. (2016) studied this question.